The fact that Medicare negotiated a price and is covering the bulk of it
Food and Drug Administration announced it will take enforcement action against non-FDA-approved compounded GLP-1 drugs that are being mass-marketed as alternatives to FDA-approved therapies
As Tecentriqs following indication may become a postoperative adjuvant therapy for early non-small cell lung cancer (NSCLC), Roche has to prepare for increased Tecentriq use in a large number of lung cancer patients
Sutapa Ghosh
Besides, the crude AF/Aflutter counts were small (13 events in each arm), raising concerns about instability of estimates, and confidence intervals appear narrow
Malaguarnera, M., Pistone, G., Elvira, R., Leotta, C., Scarpello, L., and Liborio, R